Username:
Password:
   
Create an Account
 
Account
Curriculum
Transcript
Preferences
 
Welcome & Mission Statement
FAQs
User Technical Support
Accreditation Legend
System Requirements
 
AAMC CME
ABMS
ACCME
AHRQ
AMA
CDC
MBC
 
This activity already occurred and is no longer available.
The Sixth National Clinical Conference on Cannabis Therapeutics
The Sixth National Clinical Conference on Cannabis Therapeutics, co-sponsored by the School of Medicine, University of California at San Francisco; the Rhode Island State Nurses Association and Patients Out of Time was held on April 15 - 17, 2010 at the Crowne Plaze Hotel in Warwick, RI. The Rhode Island Patient Advocacy Coalition (RIPAC) was the local host and partner with Patients Out of Time for this forum.


The Sixth National Clinical Conference on Cannabis Therapeutics

Prior to the Marihuana Tax Act of 1937, marijuana was widely used by medical doctors in the United States for a variety of physical and emotional ailments. Coupled with the bureaucratic demands of the tax act, the practice of physicians prescribing cannabis for therapeutic purposes in such an environment became subject to great scrutiny and therefore unwise. Cannabis’ therapeutic value was no longer taught in medical schools; it vanished from the pharmacopoeia of the U.S.; it became outlawed.

Cannabis, under modern research protocol, has been found to be effective in reducing intraocular pressure in glaucoma, reducing nausea and vomiting associated with chemotherapy, stimulating the appetite for persons living with AIDS and suffering from wasting syndrome, controlling spasticity associated with spinal cord injury and multiple sclerosis, reduction in the intensity of chronic pain, and controlling seizures associated with seizure disorders.

The Sixth National Clinical Conference on Cannabis Therapeutics
, co-sponsored by the School of Medicine, University of California at San Francisco, the Rhode Island State Nurses Association, and Patients Out of Time was held in the spring of 2010 and hosted by The Rhode Island Patient Advocacy Coalition (RIPAC).   The proceedings of the conference are captured here.


blue line
Learning Objectives

With the passage of Prop 215 in California and 15 other states with medical cannabis/marijuana laws, physicians can recommend cannabis for medical use.  In those states, patients are requesting this medicine and physicians need to understand pharmacology, risks and benefits, dosage and administration, and indications for its use. 

The Sixth Clinical Conference provides the evidence base to educate physicians and allied health professionals on the therapeutic use and appropriate recommendation of cannabis.  After participating in this activity, the learner should be able to:


  • List and describe at least three Cannabis-based preparations currently developed other than inhalation of cannabis-based smoke;
  • Assess the effects of at least 3 constituents of cannabis in addition to THC;
  • Accurately determine at least 3 locations of cannabinoid receptors in the human body;
  • Identify and explain at least 3 functions of the endocannabinoid system as it relates to patient treatment;
  • Discuss with patients the potential risks of impairment related to cannabis use;
  • Incorporate cannabis as a treatment option in the management of chronic pain;
  • Define your state's current legal status on the therapeutic use of cannabis.

blue line
Method of Participation
To obtain credit, participants should view the recorded video, answer the multiple-choice post-test questions, and complete the evaluation form online to receive a certificate.  Your certificate will be available immediately for print or download upon completion of the entire activity.  Make sure you have installed the newest version of Adobe Flash Player.  You will also need to have javascript enabled on your browser to load the player.  Get the latest Flash plugin here.  (See additional requirements below.)

blue line
Estimated Time
The estimated time to complete this activity is 12 hours and 45 minutes.

blue line
Media Format(s)
Recorded conference video and audio (Flash).

blue line
Released: February 12, 2012
Expires: December 31, 2014

blue line

Accreditation
The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

UCSF designates this enduring material for a maximum of 12.75
AMA PRA Category 1 Credits™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

blue line
Faculty List

Donald Abrams, MD*
Chief, Hematology-Oncology, San Francisco General Hospital 
San Francisco, CA  

Sunil Aggarwal, MD, PhD Candidate, MS-IV
University of Washington School of Medicine
Seattle, WA 

Charles Alexandre, MS, RN
Chief, Health Professions Regulation
Providence, RI 

David Bearman, MD
Practicing Physician
Board of Advisors, Patients Out of Time
Goleta, CA 

Heather Bradshaw, PhD
Assistant Professor, Psychological and Brain Sciences
Indiana University
Bloomington, IN 
 Jennifer Burbank
Mothers Against Misuse and Abuse
Park City, UT 

Al Byrne, Lcdr, USN, (ret.)* 
Co-founder and Secretary-Treasurer, Patients Out of Time
Howardsville, VA 

Martin Chilcutt, PhD
Founder, Veterans for Medical Marijuana Access
Kalamazoo, MI 

Lyle Craker, PhD
Professor, Department of Plant and Soil Services
University of Massachusetts
Amherst, MA 0 

Jose Crippa, MD, PhD
Departemento de Neurociencias e Ciencias do Comportarmento – RNC
Universidade de Sao Paulo, Brazil 

Melanie Dreher, RN, PhD, FAAN
Dean, College of Nursing
Rush University
Chicago, IL 

Gregory L. Gerdeman PhD
Assistant Professor of Biology
Eckerd College
St. Petersburg, FL

Ed Glick
Founder, Contigo-Conmigo

Monmouth, OR 

Todd E. Handel, MD*
Interventional Physiatrist 
Clinical Assistant Professor, The Warren Alpert Medical School of Brown University
Director and Chief, The Handel Center for Spine, Sports and Rehabilitation
Pawtucket, RI 

William Johnson, MD
Member, Medical Advisory Committee to the NM Medical Cannabis Program
Zia Behavioral Health
Sante Fe, NM

Michael Krawitz
Patient 100% Disabled, US Air Force
Board of Advisors, Patients Out of Time
Ferrum, VA 

Bryan Krumm, RN, CNP
Founder, New Mexicans for Compassionate Use
Board of Advisors, Patients out of Time
Albuquerque, NM 

Nathaniel Lepp, MPH*
Founder, Rhode Island Patient Advocacy Coalition 
Providence, RI 

Philippe Lucas
Center for Addictions Research of British Columbia
Vancouver Island Compassion Society
Victoria, BC 

Mary Lynn Mathre, RN, MSN, CARN, CLNC*
Co-founder & President, Patients Out of Time
Howardsville, VA 

John McPartland, MS, DO
Clinical Assistant Professor, Department of Family Medicine
University of Vermont
Middlebury, VT 

Raphael Mechoulam, PhD.
Lionel Jacobsen Professor of Medical Chemistry Endowed Chair
Hebrew University Medical Faculty, Department of Medicinal Chemistry and Natural Products
Jerusalem, Israel 

Robert Melamede PhD
Associate Professor and Biology Chairman (ret) 
Biology Department, University of Colorado
Colorado Springs, CO 

Jane Metrik, PhD
Assistant Professor (Research), Center for Alcohol and Addiction Studies
Brown University
Providence, RI 

Richard (Rik) E. Musty, PhD
Professor Emeritus of Psychology, University of Vermont
University of Vermont
Burlington, VT     

Rhonda O'Donnell
Rhode Island Cannabis Patient
Rockville, RI 

Denis Petro, MD
Practicing Neurologist & drug Researcher
Arlington, VA 

Donna Policastro, NP
Executive Director
Rhode Island State Nurses Association

Pawtucket, RI 

Jay Rostow
Chronic pain/muscle spasms
Wingina, VA 2

Jesse Stout, BA
Law Student, University of California – Hastings
Past Executive Director of RIPAC
Berkeley, CA

Reinaldo N. Takahashi, PhD
Departmento de Farmacologia
UFSC
Florianopolis-SC, Brazil

Mark A. Ware, MD, MRCP, MSc
Assistant Professor of Family Medicine and Anesthesia
McGill University, Montreal Canada.
Board of Advisers, Patients Out of Time
Montreal (Quebec) Canada

blue line
Disclosure
This UCSF CME activity was planned and developed to uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.

The faculty speakers, moderators and planning committee members have disclosed that they have NO financial interest/arrangement or affiliation with any commercial entities who have provided products or services relating to their presentation(s) or commercial support for this continuing medical education activity.


This activity has been reviewed and approved by members of the UCSF CME Governing Board in accordance with UCSF accreditation policies. Office of CME staff, planners, reviewers and all others in control of content have disclosed no relevant financial relationships.


Off-label Disclosure: This educational activity may contain discussion of unlabeled and/or investigational uses of agents that are not approved by the FDA. Please consult the prescribing information for each product.

blue line

Instructions for Obtaining Credit

After participating in the activity's content:
  1. Continue to the Post-Assessment tab to complete the post-test.  You must receive a score of 80% or better to earn a certificate.
  2. You will have an unlimited number of attempts to successfully complete the post-test.
  3. Continue on to the Evaluation tab to rate the course and to record your participation.
    1. Upon passing the post-test and completing the activity evaluation, your credit certificate will be available immediately to print for your records.
    2. You may view or print your certificate at any time in the future. 
blue line
Supplemental Material

This CME activity meets the requirements under California Assembly Bill 1195, which requires CME courses with patient care components to include curriculum in the subjects of cultural and linguistic competencies. Cultural competency is defined as a set of integrated attitudes, knowledge, and skills that enables health care professionals or organizations to care effectively for patients from diverse cultures, groups, and communities. Linguistic competency is defined as the ability of a physician or surgeon to provide patients who do not speak English or who have limited ability to speak English, direct communication in the patient’s primary language. 

Resources are available here: Cultural and Linguistic Competency Resources
blue line

UC Online Privacy Policy

https://www.cme.ucsf.edu/cme/policy.aspx 

blue line 
Software Requirements
PC
Microsoft Windows 2000 SE or above.
Internet Explorer (v5.5 or greater), or Firefox
Flash Player Plug-in (9.0 or later) Check your version here.
Sound Card & Speakers
800 x 600 Minimum Monitor Resolution (1024 x 768 Recommended)
Adobe Acrobat Reader*

MAC
MAC OS 10.2.8
Safari or Firefox
Flash Player Plug-in (9.0 or later) Check your version here.
Sound Card & Speakers
800 x 600 Minimum Monitor Resolution (1024 x 768 Recommended)
Adobe Acrobat Reader*
Internet Explorer is not supported on the Macintosh.


 * Required to view printable (PDF) version of the lesson.



 

 

UCSF School of Medicine
Office of Continuing Medical Education
3333 California Street, Suite 450
San Francisco, CA  94118

Phone: (415) 476-4251(415) 476-4251 • Fax: (415) 476-0318
Email: info@ocme.ucsf.edu • Web: http://cme.ucsf.edu

 



Type:     Internet Activity (Enduring Material)
32 Registered Users